Research & Development forms the backbone of any pharmaceutical company worth its name. Pharmix’s basic Research & Development strategy is to commercialize new drugs quickly by concentrating management resources on promising projects in fields where the Company can display its strengths, thus raising its value as a unique pharmaceutical company.

Pharmix has distinguished itself with its continued commitment to in-house research and development. In order to design and develop new products and modified dosage forms we are firmly committed to funding of R & D right from inception.

Pharmix has a team of highly qualified & experienced pharmacists who continue research in the advancement of innovative formulations & products which show great promise in the treatment of a variety of disease states.

Close communication with medical doctors, who are on the front lines of healthcare, supports Pharmix’s ability to develop pharmaceuticals from the perspective of patients. Leveraging the results of leading-edge pharmaceutical research, Pharmix develops treatments that meet the needs of patients and healthcare practitioners.

Pharmix has a pipeline of technology that will serve the medical community, patients, and consumers for years to come.